MRI developer Advanced NMR plans to merge with its Advanced MammographySystems subsidiary, of which it presently owns 61%. On completionof the deal, AMS will operate as a wholly owned subsidiary ofAdvanced NMR, of Wilmington, MA. In other Advanced NMR
MRI developer Advanced NMR plans to merge with its Advanced MammographySystems subsidiary, of which it presently owns 61%. On completionof the deal, AMS will operate as a wholly owned subsidiary ofAdvanced NMR, of Wilmington, MA.
In other Advanced NMR news, the company said that it has extendedits contract with GE Medical Systems in which ANMR is the exclusivesystems integrator for GE 3- and 4-tesla research MRI scanners.Each sale of a very-high-field scanner will result in a minimumpayment of $1.5 million to ANMR. The deal extends through 1999.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.